Clinical trial
Safety Study of Elvucitabine in HIV-1 Subjects
NCT00405249 · Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00405249 |
|---|---|
| Title | Safety Study of Elvucitabine in HIV-1 Subjects |
| Official title | 14-Day Randomized Double-Blind Comparative Viral Kinetic Study of Elvucitabine Versus Lamivudine Once Daily to HIv-1 Subjects With M184V |
| Lead sponsor | Thomas Jefferson University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | elvucitabine |
| Enrollment | 5 |
| Start date | Sep 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Nov 30, 2006 |
| Last update posted | Feb 4, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: